These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 10374692)

  • 1. CD28/CTLA-4 and CD80/CD86 families: signaling and function.
    Slavik JM; Hutchcroft JE; Bierer BE
    Immunol Res; 1999; 19(1):1-24. PubMed ID: 10374692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
    Pentcheva-Hoang T; Egen JG; Wojnoonski K; Allison JP
    Immunity; 2004 Sep; 21(3):401-13. PubMed ID: 15357951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell stimulation: an abundance of B7s.
    Abbas AK; Sharpe AH
    Nat Med; 1999 Dec; 5(12):1345-6. PubMed ID: 10581066
    [No Abstract]   [Full Text] [Related]  

  • 4. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cells and embryoid bodies express lymphocyte costimulatory molecules.
    Ling V; Munroe RC; Murphy EA; Gray GS
    Exp Cell Res; 1998 May; 241(1):55-65. PubMed ID: 9633513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of CD80 and CD86 with CD28 and CTLA4.
    Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
    J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell regulation by CD28 and CTLA-4.
    Alegre ML; Frauwirth KA; Thompson CB
    Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
    Nakajima A; Azuma M
    Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen.
    Burr JS; Kimzey SL; Randolph DR; Green JM
    Am J Respir Cell Mol Biol; 2001 May; 24(5):563-8. PubMed ID: 11350825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CD28/B7 costimulating signal and its clinical significance].
    Qu MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):265-7. PubMed ID: 12513801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell triggering by the human costimulatory molecules CD80 and CD86.
    Wilson JL; Charo J; Martín-Fontecha A; Dellabona P; Casorati G; Chambers BJ; Kiessling R; Bejarano MT; Ljunggren HG
    J Immunol; 1999 Oct; 163(8):4207-12. PubMed ID: 10510357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
    Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
    J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell proliferation-augmenting activities of the gene 3 protein derived from a phage library clone with CD80-binding activity.
    Fukumoto T; Torigoe N; Ito Y; Kajiwara Y; Sugimura K
    J Immunol; 1998 Dec; 161(12):6622-8. PubMed ID: 9862690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.